Vivimed Labs.

24
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
22.75
-1.19 (-4.97%)
BSENSE

Dec 23

BSE+NSE Vol: 9.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'23
Mar'22
Mar'21
Mar'19
Mar'18
Mar'17
No of Months
12
12
12
12
12
12
Operating Income
187.00
237.00
861.00
1,315.00
1,185.00
1,461.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
187.00
237.00
861.00
1,315.00
1,185.00
1,461.00
Expenditure (Ex Depriciation)
Stock Adjustments
84.00
0.00
-3.00
-43.00
-10.00
-29.00
Raw Materials Consumed
187.00
152.00
357.00
561.00
489.00
565.00
Power & Fuel Cost
9.00
5.00
33.00
42.00
34.00
34.00
Employee Cost
32.00
36.00
189.00
241.00
197.00
189.00
Operating Expenses
21.00
21.00
151.00
215.00
174.00
172.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
7.00
5.00
14.00
14.00
16.00
15.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
9.00
-11.00
-13.00
12.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
374.00
245.00
829.00
1,135.00
970.00
1,057.00
Operating Profit (PBDIT) excl Other Income
-186.00
-7.00
31.00
179.00
214.00
404.00
Other Income
0.00
1.00
9.00
22.00
9.00
8.00
Operating Profit (PBDIT)
-186.00
-6.00
41.00
202.00
224.00
412.00
Interest
36.00
39.00
55.00
70.00
82.00
67.00
Profit before Depriciation and Tax
-222.00
-46.00
-14.00
132.00
142.00
344.00
Depreciation
108.00
18.00
55.00
66.00
56.00
58.00
Profit Before Taxation & Exceptional Items
-330.00
-64.00
-69.00
66.00
85.00
286.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-330.00
-64.00
-69.00
66.00
85.00
286.00
Provision for Tax
-2.00
2.00
2.00
8.00
9.00
72.00
Profit After Tax
-328.00
-67.00
-71.00
57.00
76.00
213.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
78.00
146.00
224.00
607.00
533.00
318.00
Profit Available for appropriations
-249.00
78.00
152.00
665.00
611.00
532.00
Appropriations
-249.00
78.00
152.00
665.00
611.00
532.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
20.00%
20.00%
Earnings Per Share
-39.62
-8.16
-8.67
6.95
9.44
25.93
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is -21.15% vs -72.46% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is -2,286.52% vs -124.86% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is -9.40% vs -28.22% in Mar 2022

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2023 is -385.64% vs 5.89% in Mar 2022

Compare Profit and Loss Results of Vivimed Labs.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
187.00
32,643.00
-32,456.00
-99.43%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
187.00
32,643.00
-32,456.00
-99.43%
Expenditure (Ex Depriciation)
Stock Adjustments
84.00
-544.00
628.00
115.44%
Raw Materials Consumed
187.00
10,524.00
-10,337.00
-98.22%
Power & Fuel Cost
9.00
562.00
-553.00
-98.40%
Employee Cost
32.00
5,580.00
-5,548.00
-99.43%
Operating Expenses
21.00
2,563.00
-2,542.00
-99.18%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
2,925.00
-2,918.00
-99.76%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
674.00
-673.00
-99.85%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
374.00
24,096.00
-23,722.00
-98.45%
Operating Profit (PBDIT) excl Other Income
-186.00
8,547.00
-8,733.00
-102.18%
Other Income
0.00
1,097.00
-1,097.00
-100.00%
Operating Profit (PBDIT)
-186.00
9,644.00
-9,830.00
-101.93%
Interest
36.00
282.00
-246.00
-87.23%
Profit before Depriciation and Tax
-222.00
9,361.00
-9,583.00
-102.37%
Depreciation
108.00
1,703.00
-1,595.00
-93.66%
Profit Before Taxation & Exceptional Items
-330.00
7,657.00
-7,987.00
-104.31%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-330.00
7,679.00
-8,009.00
-104.30%
Provision for Tax
-2.00
1,954.00
-1,956.00
-100.10%
Profit After Tax
-328.00
5,703.00
-6,031.00
-105.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
78.00
24,998.00
-24,920.00
-99.69%
Profit Available for appropriations
-249.00
30,653.00
-30,902.00
-100.81%
Appropriations
-249.00
30,653.00
-30,902.00
-100.81%
Equity Dividend (%)
0%
800%
-800.00
Earnings Per Share
-39.62
67.89
-107.51
-158.36%
Profit And Loss - Net Sales
Net Sales 187.10 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -21.15% vs -72.46% in Mar 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -186.98 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -2,286.52% vs -124.86% in Mar 2022

Profit And Loss - Interest
Interest 36.23 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -9.40% vs -28.22% in Mar 2022

Profit And Loss - Profit After Tax
Profit After Tax -328.53 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -385.64% vs 5.89% in Mar 2022